Latham & Watkins advises Gurnet Point Capital in acquisition of Paratek Pharmaceuticals. Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company focused on the development and commercialization of...
You must be a Standard 1 Year member to access this content.
Covington & Burling LLP advised Indivior, while Latham & Watkins LLP represented Opiant in the transaction. Opiant Pharmaceuticals Inc. (NASDAQ: OPNT) has entered into a definitive...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented Endeavor in the transaction. Endeavor Group Holdings, Inc. (NYSE: EDR), a global sports and entertainment company, has entered into a definitive agreement...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Endeavor in the transaction. Endeavor (NYSE: EDR) has signed agreements to acquire nine MLB Professional Development League Clubs, as well as the creation...
You must be a Standard 1 Year member to access this content.
Cravath, Swaine & Moore represented Scientific Games Corporation in the transaction. Latham & Watkins represented Endeavor. Scientific Games Corporation (“Scientific Games”), a world leader in entertainment,...
You must be a Standard 1 Year member to access this content.
